Non-invasive electron paramagnetic resonance imaging detects tumor redox imbalance induced by ferroptosis

  • 0Laboratory of Radiation Biology, Department of Applied Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.

Summary

This summary is machine-generated.

Electron paramagnetic resonance imaging (EPRI) non-invasively detects ferroptosis, a cancer cell death mechanism. This novel redox imaging technique shows promise for in vivo cancer diagnostics and therapy monitoring.

Area Of Science

  • Oncology
  • Biomedical Imaging
  • Cell Death Mechanisms

Background

  • Ferroptosis, an iron-dependent form of cell death, and redox balance disruption are key cancer therapy targets.
  • In vivo imaging of ferroptosis remains a significant challenge in cancer research and treatment.

Purpose Of The Study

  • To investigate the application of electron paramagnetic resonance imaging (EPRI) for in vivo detection of ferroptosis.
  • To correlate redox imaging data with established ferroptosis markers in tumor tissues.

Main Methods

  • Utilized a portable electron paramagnetic resonance imaging (EPRI) device for non-invasive redox imaging of implanted tumors.
  • Administered imidazole ketone erastin (IKE), a ferroptosis-inducing agent, to tumor-bearing subjects.
  • Compared EPRI-derived redox maps with immunohistochemical images of 4-hydroxynonenal (4-HNE), a marker of lipid peroxidation.

Main Results

  • Redox maps revealed changes in tumor redox status following IKE treatment.
  • A negative correlation was observed between tumor reducing power (from EPRI) and 4-HNE-positive cell counts.
  • Distinct distributions were noted on correlation maps between control and IKE-treated groups, indicating significant differences.

Conclusions

  • Electron paramagnetic resonance imaging (EPRI) shows potential for non-invasive in vivo detection of ferroptosis.
  • Redox imaging can reflect the ferroptosis-induced changes in tumor redox status.
  • This technique may aid in monitoring ferroptosis during cancer therapy.